These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 2462612)
21. Analysis of the molecular specificities of anti-class II monoclonal antibodies by using L cell transfectants expressing HLA class II molecules. Klohe EP; Watts R; Bahl M; Alber C; Yu WY; Anderson R; Silver J; Gregersen PK; Karr RW J Immunol; 1988 Sep; 141(6):2158-64. PubMed ID: 2459201 [TBL] [Abstract][Full Text] [Related]
22. Immunochemical and functional analysis of HLA class II antigens induced by recombinant immune interferon on normal epidermal melanocytes. Tsujisaki M; Igarashi M; Sakaguchi K; Eisinger M; Herlyn M; Ferrone S J Immunol; 1987 Feb; 138(4):1310-6. PubMed ID: 3100635 [TBL] [Abstract][Full Text] [Related]
23. Mutations in the HLA class II genes leading to loss of expression of HLA-DR and HLA-DQ in diffuse large B-cell lymphoma. Jordanova ES; Philippo K; Giphart MJ; Schuuring E; Kluin PM Immunogenetics; 2003 Jul; 55(4):203-9. PubMed ID: 12756506 [TBL] [Abstract][Full Text] [Related]
24. Polymorphic DQ alpha and DQ beta interactions dictate HLA class II determinants of allo-recognition. Kwok WW; Mickelson E; Masewicz S; Milner EC; Hansen J; Nepom GT J Exp Med; 1990 Jan; 171(1):85-95. PubMed ID: 2104922 [TBL] [Abstract][Full Text] [Related]
25. Expression of MHC class II antigens (HLA-DR, -DP, and -DQ) on human gastric epithelium. Ishii N; Chiba M; Iizuka M; Watanabe H; Ishioka T; Masamune O Gastroenterol Jpn; 1992 Feb; 27(1):23-8. PubMed ID: 1555745 [TBL] [Abstract][Full Text] [Related]
26. Regulation of genes for HLA class II antigens in cell lines from patients with severe combined immunodeficiency. de Préval C; Hadam MR; Mach B N Engl J Med; 1988 May; 318(20):1295-300. PubMed ID: 3129659 [TBL] [Abstract][Full Text] [Related]
27. HLA class II mRNA accumulation by activated human T cells following growth in conditioned medium. Gansbacher B; Zier KS Clin Exp Immunol; 1989 Jun; 76(3):440-5. PubMed ID: 2546703 [TBL] [Abstract][Full Text] [Related]
28. A novel association of DQ alpha and DQ beta genes in the DRw10 haplotype. Determination of a DQw1 specificity by the DQ beta-chain. Merryman P; Silver J; Gregersen PK; Solomon G; Winchester R J Immunol; 1989 Sep; 143(6):2068-73. PubMed ID: 2476494 [TBL] [Abstract][Full Text] [Related]
29. Functional roles of the transcription factor Oct-2A and the high mobility group protein I/Y in HLA-DRA gene expression. Abdulkadir SA; Krishna S; Thanos D; Maniatis T; Strominger JL; Ono SJ J Exp Med; 1995 Aug; 182(2):487-500. PubMed ID: 7629508 [TBL] [Abstract][Full Text] [Related]
30. [Construction of mutants of MHC class II molecule transactivator gene capable of suppressing HLA-DR/DQ expression and exploration on their mechanism]. Ou QS; Lin L; Huang LD; Lu PH; Zhou GY Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2003 Sep; 19(5):417-20. PubMed ID: 15169643 [TBL] [Abstract][Full Text] [Related]
31. Mapping of the HLA-D region by pulsed-field gel electrophoresis: size variation in the DQ-DR interval. Inoko H; Ando A; Tsuji K Tokai J Exp Clin Med; 1990 May; 15(2-3):253-60. PubMed ID: 2130532 [TBL] [Abstract][Full Text] [Related]
32. Nonimmune human cells can express MHC class II antigens in the absence of invariant chain--an immunohistological study on normal and chronically inflamed small intestine. Momburg F; Koretz K; Von Herbay A; Möller P Clin Exp Immunol; 1988 Jun; 72(3):367-72. PubMed ID: 3048805 [TBL] [Abstract][Full Text] [Related]
33. Type III bare lymphocyte syndrome: lack of HLA class II gene expression and reduction in HLA class I gene expression. Sabatier C; Gimenez C; Calin-Laurens V; Rabourdin-Combe C; Touraine JL C R Acad Sci III; 1996 Sep; 319(9):789-98. PubMed ID: 8952882 [TBL] [Abstract][Full Text] [Related]
34. [Biological activity of C II TA anti-sense RNA--a novel approach to inhibition of rejection in transplantation]. Guo R; Zou P; Du X; Zhag M Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Oct; 13(5):848-51. PubMed ID: 16277856 [TBL] [Abstract][Full Text] [Related]
36. Revisiting the structural basis and energetic landscape of susceptibility difference between HLA isotypes to allergic rhinitis. Mao XL; Zhu F; Pan ZH; Wu GM; Zhu HY Comput Biol Chem; 2016 Oct; 64():210-216. PubMed ID: 27433817 [TBL] [Abstract][Full Text] [Related]
37. Class II-antigen-negative patient and mutant B-cell lines represent at least three, and probably four, distinct genetic defects defined by complementation analysis. Bénichou B; Strominger JL Proc Natl Acad Sci U S A; 1991 May; 88(10):4285-8. PubMed ID: 1852002 [TBL] [Abstract][Full Text] [Related]
38. Allorecognition of HLA-DR and -DQ transfectants by human CD45RA and CD45R0 CD4 T cells: repertoire analysis and activation requirements. Merkenschlager M; Ikeda H; Wilkinson D; Beverly PC; Trowsdale J; Fisher AG; Altmann DM Eur J Immunol; 1991 Jan; 21(1):79-88. PubMed ID: 1671359 [TBL] [Abstract][Full Text] [Related]
39. [Functional difference between HLA-DR and HLA-DQ molecules in mixed lymphocyte reaction]. Fujisawa K Fukuoka Igaku Zasshi; 1989 Jan; 80(1):49-59. PubMed ID: 2524437 [TBL] [Abstract][Full Text] [Related]
40. Expression of MHC class II antigens in human B-cell leukaemia, and increased levels of class II antigens and DR-specific mRNA after stimulation with 12-O-tetradecanoyl phorbol-13-acetate. Guy K; Meehan RR; Dewar AE; Larhammar D Immunology; 1986 Feb; 57(2):181-8. PubMed ID: 3512424 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]